Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer-Reference-Cited by-同舟云学术

Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer

Published:2023-01 Issue: Volume:178 Page:109429
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Lukovic Jelena,Hosni Ali,Liu Amy,Chen Jasmine,Tadic Tony,Patel Tirth,Li Kecheng,Han Kathy,Lindsay Patricia,Craig Tim,Brierley James,Barry Aisling,Wong Rebecca,Ringash Jolie,Dawson Laura A.,Kim John J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference34 articles.

1. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial;Ajani;J Am Med Assoc,2008

2. Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin;Gunderson;J Clin Oncol,2012

3. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial;James;Lancet Oncol,2013

4. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C;Cummings;Int J Radiat Oncol Biol Phys,1991

5. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of stage I-III squamous cell anal cancer: a comparative effectiveness systematic review;JNCI: Journal of the National Cancer Institute;2024-08-20

2. Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus;Nature Reviews Gastroenterology & Hepatology;2024-05-19

3. Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal;Advances in Radiation Oncology;2024-05

4. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review;International Journal of Radiation Oncology*Biology*Physics;2023-11